The levels of AST and gamma-glutamyl transferase (GGT) were highest in cirrhosis patients, and the levels of ALT, creatine, cholesterol, and TG were decreased compared to MASH patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.